SFJ Pharmaceuticals, Inc.
5 clinical trials · Sponsor
◉ Watch SFJ Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 With and Without Ticagrelor Pretreatment in Chinese Healthy Volunteers (NCT05162131) | SFJ Pharmaceuticals, Inc. | 2021-12-25 |
| Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure (NCT04286438) | SFJ Pharmaceuticals, Inc. | 2020-07-15 |
| Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old (NCT04122170) | SFJ Pharmaceuticals, Inc. | 2019-09-24 |
| Study to Evaluate the Safety, Tolerability, PK and PD of PB2452 in Healthy Younger, Older and Elderly Subjects (NCT03928353) | SFJ Pharmaceuticals, Inc. | 2019-04-16 |
| Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 in Healthy Volunteers (NCT03492385) | SFJ Pharmaceuticals, Inc. | 2018-04-03 |
Track SFJ Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.